Relativity-104: First-Line Relatlimab (Rela) Plus Nivolumab (Nivo) With Chemotherapy Vs Nivo With Chemotherapy In Stage Iv Or Recurrent Non-Small Cell Lung Cancer (Nsclc): A Phase Ii, Randomized, Double-Blind Study
ANNALS OF ONCOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要